Hollencrest Capital Management’s ProShares Ultra CRCL CRCA Stock Holding History

Hollencrest Capital Management’s Portfolio CRCA Stock Details CRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89.7K	Buy	+7,000	New	+$270K	0.01%	467
2026 Q1	–	Sell	-3,280	Closed	-$133K	–	1330
2025 Q4	$133K	Buy	+3,280	New	+$281K	﹤0.01%	403

Other funds holding CRCA

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Hollencrest Capital Management's CRCA Position: Q2 2026 in Review

Hollencrest Capital Management opened a new position in ProShares Ultra CRCL (CRCA) in Q2 2026: 7,000 shares worth $89.7K. The stake represents 0.01% of the portfolio and ranks #467 among its holdings. This is a return to the name: Hollencrest Capital Management previously reported a position in CRCA as recently as Q4 2025.

Hollencrest Capital Management first reported a position in CRCA in Q4 2025 and has held it in 2 quarters since. The position peaked at $133K in Q4 2025. 7 funds tracked by Wall St. Rank hold CRCA as of Q2 2026.

Hollencrest Capital Management held 7,000 shares of ProShares Ultra CRCL worth $89.7K as of Q2 2026.
ProShares Ultra CRCL was a new Hollencrest Capital Management position in Q2 2026.
ProShares Ultra CRCL made up 0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #467 holding.
Hollencrest Capital Management first reported a position in ProShares Ultra CRCL in Q4 2025 and has held it in 2 quarters since.
Hollencrest Capital Management's ProShares Ultra CRCL position peaked at $133K in Q4 2025.
7 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.